Tiotropium bromide

References

• ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel1997Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based guidelinesChest1121363969367481
   PubMed Web of Science ®Google Scholar
• [ATS] American Thoracic Society1995Statement: Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseaseAm J Respir Care Med152Suppl77121
   Google Scholar
• [ATS] American Thoracic Society1999Official Statement: Pulmonary rehabilitation-1999Am J Respir Crit Care Med15916668210228143
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEKileyJP1994Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA27214975057966841
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEEnrightPL2002Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health StudyAm J Respir Crit Care Med166333912153966
   PubMed Web of Science ®Google Scholar
• ArcasoySMKotloffRM1999Medical progress: lung transplantationN Engl J Med34010819110194239
   PubMed Web of Science ®Google Scholar
• BarnesPJMuscarinic receptor subtypes in airways1993aEur Resp J632831
   PubMed Web of Science ®Google Scholar
• BarnesPJMuscarinic receptor subtypes in airways1993bLife Sci5252178441331
   PubMed Web of Science ®Google Scholar
• BarnesPJHaddadEBRousellJ1997Regulation of muscarinic M2 receptorsLife Sci601015219121342
   PubMed Web of Science ®Google Scholar
• BarrRGBourbeauJCamargoCA2005Tiotropium for stable chronic obstructive pulmonary diseaseThe Cochrane Database of Systematic Reviews2 Art. No. CD002876.pub210.1002/14651858.CD002876.pub2.
   Web of Science ®Google Scholar
• BauerR1992The pharmacology of oxitropium bromideRev Contemp Pharmacother3197203
   Google Scholar
• BensonVMaranoMA1998Current estimates from the National Health Interview Survey, 1995Vital Health Stat 1019914289914773
   PubMedGoogle Scholar
• BraunSRLevySF1991Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center studyAm J Med91S2832
   Web of Science ®Google Scholar
• BriggsDDJrCovelliHLapidusR2005Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPDPulm Pharmacol Ther1839740416179215
   PubMed Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPW2000Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ320129730310807619
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPW2002A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J192172411866001
   PubMed Web of Science ®Google Scholar
• CasaburiRKukafkaDCooperCB2005Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPDChest1278091715764761
   PubMed Web of Science ®Google Scholar
• CelliB1997Is pulmonary rehabilitation an effective treatment for chronic obstructive pulmonary disease? YesAm J Respir Crit Care Med15578139117007
   PubMed Web of Science ®Google Scholar
• CelliBZuWallackRWangS2003Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumesChest1241743814605043
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention1999Achievements in Public Health, 1900–1999: decline in deaths from heart disease and stroke – United States, 1900–1999MMWR CDC Surveill Summ4864956
   Google Scholar
• COMBIVENT Inhalation Aerosol Study Group1994In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trialChest1051411198181328
   PubMed Web of Science ®Google Scholar
• CooperJDPattersonGASandersonRS1996Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysemaJ Thorac Cardiovasc Surg1121319308911330
   PubMed Web of Science ®Google Scholar
• CrinerGJCordovaFCFurukawaS1999Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16020182710588623
   PubMed Web of Science ®Google Scholar
• CroxtonTLWeinmannGGSeniorRM2003Clinical research in chronic obstructive pulmonary disease. needs and opportunitiesAm J Respir Crit Care Med1671142912684252
   PubMed Web of Science ®Google Scholar
• DolleryCDolleryC1991Oxitropium bromideTherapeutic drugsEdinburghLivingstone16870
   Google Scholar
• DonohueJFvan NoordJABatemanED2002A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterolChest122475512114338
   PubMed Web of Science ®Google Scholar
• DorinskyPMReisnerCFergusonGT1999The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPDChest1159667110208193
   PubMed Web of Science ®Google Scholar
• FergusonGT2000Update on pharmacologic therapy for chronic obstructive pulmonary diseaseClin Chest Med217233811194782
   PubMed Web of Science ®Google Scholar
• FishmanAP1994Pulmonary rehabilitation research: NIH workshop summaryAm J Respir Crit Care Med149825338118655
   PubMed Web of Science ®Google Scholar
• FlahertyKRCameroonEACurtisJL2001Short-term and long-term outcomes after bilateral lung volume reduction surgery: prediction by quantitative CTChest11913374611348937
   PubMed Web of Science ®Google Scholar
• GeddesDDaviesMKoyamaH2000Effect of lung-volume-reduction surgery in patients with severe emphysemaN Engl J Med3432394510911005
   PubMed Web of Science ®Google Scholar
• GhafouriMAPatilKDKassI1984Sputum changes associated with the use of ipratropium bromideChest86387936236043
   PubMed Web of Science ®Google Scholar
• GrossNJ1988Ipratropium bromideN Engl J Med319486942970009
   PubMed Web of Science ®Google Scholar
• HattotuwaKLGizyckiMJAnsariTW2002The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy studyAm J Respir Crit Care Med1651592612070058
   PubMed Web of Science ®Google Scholar
• HayJGStonePCarterJ1992Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary diseaseEur Respir J5659641628722
   PubMed Web of Science ®Google Scholar
• KarpelJP1991Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPDChest9987161672634
   PubMed Web of Science ®Google Scholar
• KotloffRMHansen-FlaschenJLipsonDA2001Apical perfusion fraction as a predictor of short term functional outcome following bilateral lung volume reduction surgeryChest12016091511713142
   PubMed Web of Science ®Google Scholar
• LipsonDA2004Redefining treatment in COPD: new directions in bronchodilator therapyTreat Respir Med38995 Erratum in Treat Respir Med, 3:18115182210
   PubMedGoogle Scholar
• The Lung Health Study Research Group2000Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med3431902911136260
   PubMed Web of Science ®Google Scholar
• MahlerDAWirePHorstmanD2002Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in the treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16610849112379552
   PubMed Web of Science ®Google Scholar
• MakJCHaddadEBBuckleyNJ1993Visualization of muscarinic M4 mRNA and M4 receptor subtype in rabbit lungLife Sci53150188412514
   PubMed Web of Science ®Google Scholar
• MaltaisFHamiltonAMarciniukD2005Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPDChest12811687816162703
   PubMed Web of Science ®Google Scholar
• ManninoDMHomaDMAkinbamiLJ2002Chronic obstructive pulmonary disease surveillance – United States, 1971–2000MMWR Surveill Summ51116
   PubMed Web of Science ®Google Scholar
• MartinRJBartelsonBLSmithP1999Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPDChest11513384510334150
   PubMed Web of Science ®Google Scholar
• McNicholasWTCalverleyPMALeeA2004Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPDEur Resp J2382531
   PubMed Web of Science ®Google Scholar
• Medical Research Council Working Party1981Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysemaLancet168166110912
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezAD1997aRegional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease StudyLancet3491347529149696
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezAD1997bGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease StudyLancet3491436429164317
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezAD1997cAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet34914985049167458
   PubMed Web of Science ®Google Scholar
• National Emphysema Treatment Trial Research Group2001Patients at high risk of mortality from lung volume reduction surgeryN Engl J Med34510758311596586
   PubMed Web of Science ®Google Scholar
• National Emphysema Treatment Trial Research Group2003A randomized trial comparing lung-volume–reduction surgery with medical therapy for severe emphysemaN Engl J Med34820597312759479
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute1998Morbidity and mortality: Chartbook on cardiovascular, lung, and blood diseasesBethesda, MDUS Department of Health and Human Services, Public Health Service, NIH
   Google Scholar
• Nocturnal Oxygen Therapy Trial Group1980Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung diseaseAnn Int Med9339186776858
   PubMed Web of Science ®Google Scholar
• NiewoehnerDERiceKCoteC2005Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator. A randomized trialAnn Int Med1433172616144890
   PubMed Web of Science ®Google Scholar
• O’DonnellDELamMWebbKA1998Measurements of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1581557659817708
   PubMed Web of Science ®Google Scholar
• RennardSISerbyCWGhafouri1996Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trialsChest11062708681667
   PubMed Web of Science ®Google Scholar
• SciurbaFCRogersRMKeenanRJ1996Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysemaN Engl J Med334109598598868
   PubMed Web of Science ®Google Scholar
• SinDDTuJV2001Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med164580411520719
   PubMed Web of Science ®Google Scholar
• SpenceDPHayJGCarterJ1993Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromideThorax481145508296259
   PubMed Web of Science ®Google Scholar
• TarpSPCelliBR1995Long-term oxygen therapyN Engl J Med333710147637750
   PubMed Web of Science ®Google Scholar
• TaubeCLehnigkBPaaschK2000Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1622162010903244
   PubMed Web of Science ®Google Scholar
• TsukinoMNishimuraKIkedaA1998Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary diseaseThorax53269739741369
   PubMed Web of Science ®Google Scholar
• VathenenASBrittonJREbdenP1988High-dose inhaled albuterol in severe chronic airflow limitationAm Rev Respir Dis13885052462383
   PubMed Web of Science ®Google Scholar
• van NoordJAde MunckDRBantjeTA2000Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropiumEur Respir J158788510853852
   PubMed Web of Science ®Google Scholar
• van NoordJAAumannJ-LJanssensE2005Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPDEur Resp J2621422
   PubMed Web of Science ®Google Scholar
• VinckenWvan NoordJAGreefhorstAPDutch/Belgian Tiotropium Study Group2002Improved health outcomes in patients with COPD during 1 year’s treatment with tiotropiumEur Respir J192091611871363
   PubMed Web of Science ®Google Scholar
• WiltTJNiewoehnerDKimC2005Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD)Evidence Report/Technology Assessment, nr 121:1–7 AHRQ Publication No 05-E017-2Rockville, MD, USAAgency for Healthcare Research and Quality
   Google Scholar
• ZuWallackARZuWallackRL2004Tiotropium bromide, a new once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary diseaseExpert Opin Pharmacother518273515264997
   PubMed Web of Science ®Google Scholar